Simethicone as Part of ERAS in Bariatric Surgery Patients

Recruiting Phase 4 Interventional Study
Simethicone Bariatric Surgery Post-operative Pain
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 89
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
260 (estimated)
Sponsor
Madigan Army Medical Center · Federal
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Foregut procedures Exclusion Criteria: * Non-foregut procedures * Allergy to simethicone * Pregnancy or breastfeeding * Minors under 18 years of age
Contacts

Brooklyn Williams, DO

(253) 968-3105

brooklyn.c.williams3.mil@health.mil

CONTACT

Christopher Porta, MD

(253) 968-3105

christopher.r.porta.civ@health.mil

CONTACT